These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11174904)

  • 1. The cardiovascular and metabolic complications of HIV infection.
    Krishnaswamy G; Chi DS; Kelley JL; Sarubbi F; Smith JK; Peiris A
    Cardiol Rev; 2000; 8(5):260-8. PubMed ID: 11174904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular disease in HIV infection.
    Sudano I; Spieker LE; Noll G; Corti R; Weber R; Lüscher TF
    Am Heart J; 2006 Jun; 151(6):1147-55. PubMed ID: 16781213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
    Boccara F
    AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-related cardiovascular disease and drug interactions.
    Nanavati KA; Fisher SD; Miller TL; Lipshultz SE
    Am J Cardiovasc Drugs; 2004; 4(5):315-24. PubMed ID: 15449973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection.
    Tanwani LK; Mokshagundam SL
    South Med J; 2003 Feb; 96(2):180-8; quiz 189. PubMed ID: 12630645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat.
    Wang T; Yi R; Green LA; Chelvanambi S; Seimetz M; Clauss M
    Cardiovasc Pathol; 2015; 24(5):279-82. PubMed ID: 26233281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus.
    Grinspoon SK
    Am J Med; 2005 Apr; 118 Suppl 2():23S-28S. PubMed ID: 15903292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk and dyslipidemia among persons living with HIV: a review.
    Maggi P; Di Biagio A; Rusconi S; Cicalini S; D'Abbraccio M; d'Ettorre G; Martinelli C; Nunnari G; Sighinolfi L; Spagnuolo V; Squillace N
    BMC Infect Dis; 2017 Aug; 17(1):551. PubMed ID: 28793863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease associated with human immunodeficiency virus: a review.
    Costa LA; Almeida AG
    Rev Port Cardiol; 2015; 34(7-8):479-91. PubMed ID: 26162286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease and therapeutic drug-related cardiovascular consequences in HIV-infected patients.
    Fisher SD; Kanda BS; Miller TL; Lipshultz SE
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):383-94. PubMed ID: 22149317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of HIV: lipodystrophy, anemia, renal, cardiovascular, and bone diseases.
    Balt CA; Nixon H
    Nurse Pract Forum; 2001 Dec; 12(4):199-213. PubMed ID: 11889688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular manifestations in human immunodeficiency virus-infected patients.
    Khunnawat C; Mukerji S; Havlichek D; Touma R; Abela GS
    Am J Cardiol; 2008 Sep; 102(5):635-42. PubMed ID: 18721528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in lipid metabolism of patients infected by human immunodeficiency virus. A pathogenic hypothesis].
    Rodríguez Vidigal FF; Muñoz Sanz A
    Med Clin (Barc); 2000 Jun; 115(4):145-50. PubMed ID: 10996887
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.
    Hadigan C; Meigs JB; Corcoran C; Rietschel P; Piecuch S; Basgoz N; Davis B; Sax P; Stanley T; Wilson PW; D'Agostino RB; Grinspoon S
    Clin Infect Dis; 2001 Jan; 32(1):130-9. PubMed ID: 11118392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients.
    Barbaro G; Klatt EC
    Curr Pharm Des; 2003; 9(18):1475-81. PubMed ID: 12769727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key reports from the 9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV 2007.
    Nestorowicz A; Cameron S
    Antivir Ther; 2007; 12(6):987-98. PubMed ID: 17926655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection, highly active antiretroviral therapy and the cardiovascular system.
    Barbaro G
    Cardiovasc Res; 2003 Oct; 60(1):87-95. PubMed ID: 14522410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease in HIV infection.
    Sánchez-Torres RJ; García-Palmieri MR
    P R Health Sci J; 2006 Sep; 25(3):249-54. PubMed ID: 17203795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease and toxicities related to HIV infection and its therapies.
    Zareba KM; Miller TL; Lipshultz SE
    Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.